Citius Wins FDA Nod for Lymphir in Cutaneous T-cell Lymphoma
Citius Pharma Analyst Ratings
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
Earnings Call Summary | Xeris Pharmaceuticals(XERS.US) Q2 2024 Earnings Conference
Olema Pharmaceuticals Analyst Ratings
Immunovant Analyst Ratings